Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation Is Achievable.

Publication ,  Journal Article
Piccini, JP; Xu, H; Cox, M; Matsouaka, RA; Fonarow, GC; Butler, J; Curtis, AB; Desai, N; Fang, M; McCabe, PJ; Page Ii, RL; Turakhia, M ...
Published in: Circulation
March 19, 2019

BACKGROUND: Efforts to improve prescription of oral anticoagulation (OAC) drugs in patients with atrial fibrillation have had limited success in improving guideline adherence. METHODS: We evaluated adherence to the American College of Cardiology/American Heart Association performance measures for OAC in eligible patients with a CHA2DS2-VASc score ≥2 and trends in prescription over time in the American Heart Association's Get With The Guidelines-AFIB (atrial fibrillation) registry. Adjusted associations with in-hospital outcomes were also determined. The cohort included 33 235 patients with a CHA2DS2-VASc score ≥2 who were admitted for atrial fibrillation and were enrolled at 115 sites between January 1, 2013, and September 31, 2017. RESULTS: The median (25th, 75th percentile) age was 73 years (65, 81 years); 51% were female; and the median (25th, 75th percentile) CHA2DS2-VASc score was 4 (3, 5). At admission, 16 206 (59.5%) of 27 221 patients with a previous diagnosis of atrial fibrillation were taking OAC agents, and OAC drug use at admission was associated with a lower adjusted odds of in-hospital ischemic stroke (odds ratio, 0.38; 95% CI, 0.24-0.59; P<0.0001). At discharge, prescription of OAC in eligible patients (no contraindications) was 93.5% (n=25 499 of 27 270). In a sensitivity analysis, when excluding only strict contraindications (4.6%, n=1497 of 32 806), OAC prescription at discharge was 80.3%. OAC prescription at discharge was higher in those aged ≤75 years, men, those with heart failure, those with previous atrial fibrillation ablation, and those with rhythm control ( P<0.0001 for all). OAC use was lowest in Hispanic patients (90.2%, P<0.0001). Prescription of OAC at discharge in eligible patients improved over time from 79.9% to 96.6% ( P<0.0001). CONCLUSIONS: Among hospitals participating in the GWTG-AFIB quality improvement program, OAC prescription at discharge in eligible guideline-indicated patients increased significantly and improved consistently over time. These data confirm that high-level adherence to guideline-recommended stroke prevention is achievable.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

March 19, 2019

Volume

139

Issue

12

Start / End Page

1497 / 1506

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Stroke
  • Severity of Illness Index
  • Registries
  • Quality Improvement
  • Patient Discharge
  • Odds Ratio
  • Male
  • Humans
  • Guideline Adherence
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Piccini, J. P., Xu, H., Cox, M., Matsouaka, R. A., Fonarow, G. C., Butler, J., … Get With The Guidelines-AFIB Clinical Working Group and Hospitals, . (2019). Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation Is Achievable. Circulation, 139(12), 1497–1506. https://doi.org/10.1161/CIRCULATIONAHA.118.035909
Piccini, Jonathan P., Haolin Xu, Margueritte Cox, Roland A. Matsouaka, Gregg C. Fonarow, Javed Butler, Anne B. Curtis, et al. “Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation Is Achievable.Circulation 139, no. 12 (March 19, 2019): 1497–1506. https://doi.org/10.1161/CIRCULATIONAHA.118.035909.
Piccini JP, Xu H, Cox M, Matsouaka RA, Fonarow GC, Butler J, et al. Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation Is Achievable. Circulation. 2019 Mar 19;139(12):1497–506.
Piccini, Jonathan P., et al. “Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation Is Achievable.Circulation, vol. 139, no. 12, Mar. 2019, pp. 1497–506. Pubmed, doi:10.1161/CIRCULATIONAHA.118.035909.
Piccini JP, Xu H, Cox M, Matsouaka RA, Fonarow GC, Butler J, Curtis AB, Desai N, Fang M, McCabe PJ, Page Ii RL, Turakhia M, Russo AM, Knight BP, Sidhu M, Hurwitz JL, Ellenbogen KA, Lewis WR, Get With The Guidelines-AFIB Clinical Working Group and Hospitals. Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation Is Achievable. Circulation. 2019 Mar 19;139(12):1497–1506.

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

March 19, 2019

Volume

139

Issue

12

Start / End Page

1497 / 1506

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Stroke
  • Severity of Illness Index
  • Registries
  • Quality Improvement
  • Patient Discharge
  • Odds Ratio
  • Male
  • Humans
  • Guideline Adherence